Eribulin and Confusion: A Previously Unknown Drug Side-Effect

Eribulin and Confusion: A Previously Unknown Drug Side-Effect

Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman trea...

Full description

Bibliographic Details
Main Authors: Abu Baker Sheikh, Abhilash Perisetti, Nismat Javed, Rahul Shekhar
Format: Article
Language:English
Published: SMC MEDIA SRL 2020-06-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
eribulin
encephalopathy
breast cancer
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/1708

Similar Items

Similar Items